IBDEI12V ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39132,1,3,0)
 ;;=3^Hb-SS Disease w/ Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,39132,1,4,0)
 ;;=4^D57.00
 ;;^UTILITY(U,$J,358.3,39132,2)
 ;;=^5002306
 ;;^UTILITY(U,$J,358.3,39133,0)
 ;;=D57.02^^148^1947^82
 ;;^UTILITY(U,$J,358.3,39133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39133,1,3,0)
 ;;=3^Hb-SS Disease w/ Splenic Sequestration
 ;;^UTILITY(U,$J,358.3,39133,1,4,0)
 ;;=4^D57.02
 ;;^UTILITY(U,$J,358.3,39133,2)
 ;;=^5002308
 ;;^UTILITY(U,$J,358.3,39134,0)
 ;;=D68.32^^148^1947^84
 ;;^UTILITY(U,$J,358.3,39134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39134,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
 ;;^UTILITY(U,$J,358.3,39134,1,4,0)
 ;;=4^D68.32
 ;;^UTILITY(U,$J,358.3,39134,2)
 ;;=^5002357
 ;;^UTILITY(U,$J,358.3,39135,0)
 ;;=C22.2^^148^1947^85
 ;;^UTILITY(U,$J,358.3,39135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39135,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,39135,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,39135,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,39136,0)
 ;;=D58.9^^148^1947^87
 ;;^UTILITY(U,$J,358.3,39136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39136,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,39136,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,39136,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,39137,0)
 ;;=C81.99^^148^1947^88
 ;;^UTILITY(U,$J,358.3,39137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39137,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,39137,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,39137,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,39138,0)
 ;;=C81.90^^148^1947^89
 ;;^UTILITY(U,$J,358.3,39138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39138,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,39138,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,39138,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,39139,0)
 ;;=D89.2^^148^1947^90
 ;;^UTILITY(U,$J,358.3,39139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39139,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,39139,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,39139,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,39140,0)
 ;;=D05.12^^148^1947^91
 ;;^UTILITY(U,$J,358.3,39140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39140,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,39140,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,39140,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,39141,0)
 ;;=D05.11^^148^1947^92
 ;;^UTILITY(U,$J,358.3,39141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39141,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,39141,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,39141,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,39142,0)
 ;;=D05.10^^148^1947^93
 ;;^UTILITY(U,$J,358.3,39142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39142,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,39142,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,39142,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,39143,0)
 ;;=D50.0^^148^1947^94
 ;;^UTILITY(U,$J,358.3,39143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39143,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,39143,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,39143,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,39144,0)
 ;;=D50.9^^148^1947^95
 ;;^UTILITY(U,$J,358.3,39144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39144,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,39144,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,39144,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,39145,0)
 ;;=C46.9^^148^1947^96
 ;;^UTILITY(U,$J,358.3,39145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39145,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,39145,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,39145,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,39146,0)
 ;;=C22.0^^148^1947^97
 ;;^UTILITY(U,$J,358.3,39146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39146,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,39146,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,39146,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,39147,0)
 ;;=D05.02^^148^1947^98
 ;;^UTILITY(U,$J,358.3,39147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39147,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,39147,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,39147,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,39148,0)
 ;;=D05.01^^148^1947^99
 ;;^UTILITY(U,$J,358.3,39148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39148,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,39148,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,39148,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,39149,0)
 ;;=D05.00^^148^1947^100
 ;;^UTILITY(U,$J,358.3,39149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39149,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,39149,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,39149,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,39150,0)
 ;;=R59.0^^148^1947^61
 ;;^UTILITY(U,$J,358.3,39150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39150,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,39150,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,39150,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,39151,0)
 ;;=C83.59^^148^1947^101
 ;;^UTILITY(U,$J,358.3,39151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39151,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,39151,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,39151,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,39152,0)
 ;;=C83.50^^148^1947^102
 ;;^UTILITY(U,$J,358.3,39152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39152,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,39152,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,39152,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,39153,0)
 ;;=C43.9^^148^1947^104
 ;;^UTILITY(U,$J,358.3,39153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39153,1,3,0)
 ;;=3^Malig Melanoma of Skin,Unspec Site
 ;;^UTILITY(U,$J,358.3,39153,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,39153,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,39154,0)
 ;;=C31.9^^148^1947^105
 ;;^UTILITY(U,$J,358.3,39154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39154,1,3,0)
 ;;=3^Malig Neop Accessory Sinus,Unspec
 ;;^UTILITY(U,$J,358.3,39154,1,4,0)
 ;;=4^C31.9
 ;;^UTILITY(U,$J,358.3,39154,2)
 ;;=^5000953
 ;;^UTILITY(U,$J,358.3,39155,0)
 ;;=C24.1^^148^1947^107
 ;;^UTILITY(U,$J,358.3,39155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39155,1,3,0)
 ;;=3^Malig Neop Ampulla of Vater
 ;;^UTILITY(U,$J,358.3,39155,1,4,0)
 ;;=4^C24.1
 ;;^UTILITY(U,$J,358.3,39155,2)
 ;;=^267100
 ;;^UTILITY(U,$J,358.3,39156,0)
 ;;=C21.0^^148^1947^108
 ;;^UTILITY(U,$J,358.3,39156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39156,1,3,0)
 ;;=3^Malig Neop Anus,Unspec
 ;;^UTILITY(U,$J,358.3,39156,1,4,0)
 ;;=4^C21.0
 ;;^UTILITY(U,$J,358.3,39156,2)
 ;;=^5000930
 ;;^UTILITY(U,$J,358.3,39157,0)
 ;;=C67.9^^148^1947^111
 ;;^UTILITY(U,$J,358.3,39157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39157,1,3,0)
 ;;=3^Malig Neop Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,39157,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,39157,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,39158,0)
 ;;=C71.9^^148^1947^115
 ;;^UTILITY(U,$J,358.3,39158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39158,1,3,0)
 ;;=3^Malig Neop Brain,Unspec
 ;;^UTILITY(U,$J,358.3,39158,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,39158,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,39159,0)
 ;;=C18.9^^148^1947^117
 ;;^UTILITY(U,$J,358.3,39159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39159,1,3,0)
 ;;=3^Malig Neop Colon,Unspec
 ;;^UTILITY(U,$J,358.3,39159,1,4,0)
 ;;=4^C18.9
 ;;^UTILITY(U,$J,358.3,39159,2)
 ;;=^5000929
 ;;^UTILITY(U,$J,358.3,39160,0)
 ;;=C49.9^^148^1947^118
